Clinical Trial Update: Study of MK-4464 as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced/Metastatic Solid Tumors (MK-4464-001) [Phase 1]

View source ↗

Summary

This Phase 1 trial update reports on MK-4464 as a monotherapy and in combination with pembrolizumab for participants with advanced or metastatic solid tumors, n…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neoplasms
• Solid Tumors

Drugs mentioned

• MK-4464
• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Advanced/Metastatic Solid Tumors, Neoplasms | Phase 1 | Status: COMPLETED